Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Spencer

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Neuroscience and Biobehavioral Reviews|February 15, 2023
Belief updating in psychosis, depression and anxiety disorders: A systematic review across computational modelling approachesToni Gibbs-Dean, Teresa Katthagen, Iveta Tsenkova, et al.
Journal of Child and Adolescent Psychopharmacology|August 26, 2009
Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorderAnn C Childress, Thomas Spencer, Frank Lopez, et al.
Pediatrics|May 3, 2003
Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatmentJoseph Biederman, Stephen V Faraone, Michael C Monuteaux, et al.
Journal of Child and Adolescent Psychopharmacology|September 30, 2005
Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorderStephen V Faraone, Joseph Biederman, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation studyLenard A Adler, Brenda Zimmerman, H Lynn Starr, et al.
Tissue Engineering. Part C, Methods|April 9, 2009
Use of iodixanol self-generated density gradients to enrich for viable urothelial cells from nonneurogenic and neurogenic bladder tissueAndrew T Bruce, Namrata Sangha, Allison Richmond, et al.
The American Journal of Psychiatry|March 5, 2008
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up studyJoseph Biederman, Michael C Monuteaux, Thomas Spencer, et al.
Schizophrenia Bulletin|April 19, 2020
Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort StudyPaolo Fusar-Poli, Andrea De Micheli, Rashmi Patel, et al.
The Journal of Pediatrics|April 28, 2009
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorderPaul Hammerness, Timothy Wilens, Eric Mick, et al.
Journal of ADHD & Related Disorders|April 14, 2012
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use DisordersTimothy E Wilens, Jefferson B Prince, James Waxmonsky, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Neuroscience and Biobehavioral Reviews|February 15, 2023
Belief updating in psychosis, depression and anxiety disorders: A systematic review across computational modelling approachesToni Gibbs-Dean, Teresa Katthagen, Iveta Tsenkova, et al.
Journal of Child and Adolescent Psychopharmacology|August 26, 2009
Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorderAnn C Childress, Thomas Spencer, Frank Lopez, et al.
Pediatrics|May 3, 2003
Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatmentJoseph Biederman, Stephen V Faraone, Michael C Monuteaux, et al.
Journal of Child and Adolescent Psychopharmacology|September 30, 2005
Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorderStephen V Faraone, Joseph Biederman, Thomas Spencer, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation studyLenard A Adler, Brenda Zimmerman, H Lynn Starr, et al.
Tissue Engineering. Part C, Methods|April 9, 2009
Use of iodixanol self-generated density gradients to enrich for viable urothelial cells from nonneurogenic and neurogenic bladder tissueAndrew T Bruce, Namrata Sangha, Allison Richmond, et al.
The American Journal of Psychiatry|March 5, 2008
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up studyJoseph Biederman, Michael C Monuteaux, Thomas Spencer, et al.
Schizophrenia Bulletin|April 19, 2020
Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort StudyPaolo Fusar-Poli, Andrea De Micheli, Rashmi Patel, et al.
The Journal of Pediatrics|April 28, 2009
Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorderPaul Hammerness, Timothy Wilens, Eric Mick, et al.
Journal of ADHD & Related Disorders|April 14, 2012
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use DisordersTimothy E Wilens, Jefferson B Prince, James Waxmonsky, et al.
Pageof 11